Premium
Direct medical costs of diabetes mellitus in the year of mortality and year preceding the year of mortality
Author(s) -
Wong Carlos K. H.,
Jiao Fangfang,
Tang Eric H. M.,
Tong Thaison,
Thokala Praveen,
Lam Cindy L. K.
Publication year - 2018
Publication title -
diabetes, obesity and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.445
H-Index - 128
eISSN - 1463-1326
pISSN - 1462-8902
DOI - 10.1111/dom.13253
Subject(s) - medicine , diabetes mellitus , mortality rate , indirect costs , cause of death , population , demography , cohort , emergency medicine , standardized mortality ratio , medical costs , retrospective cohort study , environmental health , health care , disease , accounting , sociology , business , endocrinology , economic growth , economics
Aim To report the health resource use and estimate the direct medical costs among patients with diabetes mellitus (DM) in the year of mortality and the year preceding the year of mortality. Materials and methods We analysed data from a population‐based, retrospective cohort study including all adults with a DM diagnosis in Hong Kong between 2009 and 2013, and who died between January 1, 2010 and December 31, 2013. The annual direct medical costs in the year of mortality and the year preceding the year of mortality were determined by summing the costs of health services utilized within the respective year. The costs were analysed by gender, the presence of comorbidities, diabetic complications and primary cause of death. Results A total of 10 649 patients met the eligibility criteria for analysis. On average, the direct medical costs in the year of death were 1.947 times higher than those in the year before death. Men and women with DM incurred similar costs in the year preceding the year of mortality and in the mortality year. Patients with any diabetic complications incurred greater costs in the year of mortality and the year before mortality than those without. Conclusions This analysis provides new evidence on incorporating additional direct medical costs in the mortality year, and refining the structure of total cost estimates for use in costing and cost‐effectiveness analyses of interventions for DM.